Skip to Main Content

Advertisement

Skip Nav Destination
Issue Cover
Current Issue
Volume 8,
Issue 4,
February 27 2024

Advertisement




Featured Content

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Novel GNE missense variants impair de novo sialylation and cause defective angiogenesis in the developing brain in mice

Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial

FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia

A thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulation

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement